Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Pathology Weekly Reading Notes by “Maimai” | Issue 3

Continue reading
06 2 月

Prognosis-Related Proteins in Breast Cancer and Their Expression Significance

Continue reading
06 2 月

Common Issues, Cause Analysis, and Solutions in Immunohistochemical Staining Techniques

Continue reading
06 2 月

Recent Pathological Diagnoses of Several Rare Pediatric Tumors or Diseases

Continue reading
06 2 月

Memorable Moments at the 15th Anniversary Gala Dinner of “Maxim & Chinese Journal of Pathology”

Continue reading
06 2 月

Brief Overview of the Important Role of Immunohistochemistry

Continue reading
06 2 月

What’s New in the World of Pathology?

Continue reading
06 2 月

Positive Expression Rates of CDX2 and Villin at Moderate Intensity or Above in Adenocarcinoma

Continue reading
06 2 月

21st Issue of “Maimai” Pathology Weekly Reading Notes | Overview of Immunohistochemical Markers for Diagnosis of Endocrine and Neuroendocrine Tumors

Continue reading
06 2 月

The Pain Points of “The Foundation of Medicine”: Standardization and Quality Control in Immunohistochemistry

Continue reading
  • «
  • ‹
  • 10
  • 11
  • 12
  • 13
  • 14
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar